AGL 38.48 Decreased By ▼ -0.08 (-0.21%)
AIRLINK 203.02 Decreased By ▼ -4.75 (-2.29%)
BOP 10.17 Increased By ▲ 0.11 (1.09%)
CNERGY 6.54 Decreased By ▼ -0.54 (-7.63%)
DCL 9.58 Decreased By ▼ -0.41 (-4.1%)
DFML 40.02 Decreased By ▼ -1.12 (-2.72%)
DGKC 98.08 Decreased By ▼ -5.38 (-5.2%)
FCCL 34.96 Decreased By ▼ -1.39 (-3.82%)
FFBL 86.43 Decreased By ▼ -5.16 (-5.63%)
FFL 13.90 Decreased By ▼ -0.70 (-4.79%)
HUBC 131.57 Decreased By ▼ -7.86 (-5.64%)
HUMNL 14.02 Decreased By ▼ -0.08 (-0.57%)
KEL 5.61 Decreased By ▼ -0.36 (-6.03%)
KOSM 7.27 Decreased By ▼ -0.59 (-7.51%)
MLCF 45.59 Decreased By ▼ -1.69 (-3.57%)
NBP 66.38 Decreased By ▼ -7.38 (-10.01%)
OGDC 220.76 Decreased By ▼ -1.90 (-0.85%)
PAEL 38.48 Increased By ▲ 0.37 (0.97%)
PIBTL 8.91 Decreased By ▼ -0.36 (-3.88%)
PPL 197.88 Decreased By ▼ -7.97 (-3.87%)
PRL 39.03 Decreased By ▼ -0.82 (-2.06%)
PTC 25.47 Decreased By ▼ -1.15 (-4.32%)
SEARL 103.05 Decreased By ▼ -7.19 (-6.52%)
TELE 9.02 Decreased By ▼ -0.21 (-2.28%)
TOMCL 36.41 Decreased By ▼ -1.80 (-4.71%)
TPLP 13.75 Decreased By ▼ -0.02 (-0.15%)
TREET 25.12 Decreased By ▼ -1.33 (-5.03%)
TRG 58.04 Decreased By ▼ -2.50 (-4.13%)
UNITY 33.67 Decreased By ▼ -0.47 (-1.38%)
WTL 1.71 Decreased By ▼ -0.17 (-9.04%)
BR100 11,890 Decreased By -408.8 (-3.32%)
BR30 37,357 Decreased By -1520.9 (-3.91%)
KSE100 111,070 Decreased By -3790.4 (-3.3%)
KSE30 34,909 Decreased By -1287 (-3.56%)

KARACHI: Dr Emily Kaine, Senior Vice President, Global Health and Manufacturing Services, United States Pharmacopeial Convention (USP) and Waqas Ahmed, Chief of Party US Pharmacopeia (USP) PQM+ Pakistan visited PharmEvo, the country’s leading pharmaceutical company, which has recently achieved the World Health Organization’s Pre-Qualification of Zinc Sulfate syrup and dispersible tablets to treat diarrhoea in Pakistan.

USP is an independent, scientific non-profit organization focused on building trust in the supply of safe, quality medicines.

Similarly, PQM+ under the US Agency for International Development (USAID) helps improve the quality and expands the supply of essential medical products in more than 20 countries by sustainably strengthening medicines regulatory authorities and local pharmaceutical manufacturers.

Dr Emily Kaine congratulated PharmEvo for achieving the landmark WHO prequalification of Zinc Sulfate syrup and tablets, saying this will help minimise the mortality rate of children under five-years of age because of diarrhoea.

Being first in the world to obtain WHO pre-qualified Zinc Sulfate syrup status, PharmEvo looks forward to its contribution to ensure that children receive a standardized and quality-assured product not only in Pakistan but all over the world increasing the chances of successful treatment and improving overall child health.

The WHO pre-qualified Zinc Sulfate syrup would play a crucial role in addressing the health needs of children across Pakistan amid growing cases of diarrhoea which has become a leading cause of childhood morbidity and mortality in the country.

Dr Emily Kaine also visited the manufacturing site of PharmEvo and appreciated the quality standards observed of the company.

She was briefed about the company’s strict requirements for maintaining quality and meeting the required standards.

PharmEvo's leadership appreciated the technical support provided by USP’s PQM Plus to PharmEvo in order to pre-qualify for Zinc Sulfate dispersible tablet and oral solution.

The two sides exchanged their thoughts, discussed future prospects of medicines in Pakistan and role of local pharmaceutical manufacturers for quality production.

Copyright Business Recorder, 2023

Comments

Comments are closed.